美国LipoScience
LipoScience是领先的生物分析诊断公司，主要使用核磁共振方法（NMR）通过分析血液中脂蛋白的成分进行心血管疾病的分级。这项技术由于北卡州立大学生物化学专家James Otvos提出，他目前是该公司的首席科学顾问。测试结果目前已广泛得到Mdeicare，TRICARE，WellPoint，United HealthCare 等医疗保险公司认可。
LipoScience 开创了一个基于 NMR 技术进行个性化诊断的新领域。加强并拓宽我们的专有诊断测试能力

LipoScience is a highly innovative, diagnostic company focused on changing the way heart disease, diabetes* and other metabolic diseases are assessed and managed.

We develop proprietary tests based on Nuclear Magnetic Resonance (NMR), an information-rich technology that produces a digital representation of the molecules present in a simple blood sample.

Over 8 million tests performed since 1999 to benefit physicians and their patients. This test directly measures lipoprotein particles and provides physicians and their patients more information to manage their risk for heart disease and diabetes.

The company is preparing to decentralize its proprietary platform with a broad array of high value NMR based assays, in support of driving toward new clinical standards of care.

We have broad opportunities for growth in our diagnostic, research, and laboratory businesses. We are actively pursuing these opportunities with the support of our employees, our customers, and our industry partners.

* The LP-IR test is only available through the LipoScience laboratory.